Universität zu Köln

Wirtz, R. M., Leinonen, M., Bono, P., Isola, J., Kellokumpu-Lehtinen, P-L, Kataja, V., Turpeenniemi-Hujanen, T., Jyrkkio, S., Eidt, S., Schmidt, M. and Joensuu, H. (2013). Low tumor CD68 mRNA content (intratumoral macrophages) is predictive for benefit from adjuvant trastuzumab in HER2-positive breast cancer: An analysis of the FinHER trial. Cancer Res., 73. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Full text not available from this repository.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Wirtz, R. M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Leinonen, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Bono, P. UNSPECIFIED UNSPECIFIED UNSPECIFIED Isola, J. UNSPECIFIED UNSPECIFIED UNSPECIFIED Kellokumpu-Lehtinen, P-L UNSPECIFIED UNSPECIFIED UNSPECIFIED Kataja, V. UNSPECIFIED UNSPECIFIED UNSPECIFIED Turpeenniemi-Hujanen, T. UNSPECIFIED UNSPECIFIED UNSPECIFIED Jyrkkio, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Eidt, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Schmidt, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Joensuu, H. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-470104
DOI:	10.1158/0008-5472.SABCS13-P1-08-06
Journal or Publication Title:	Cancer Res.
Volume:	73
Date:	2013
Publisher:	AMER ASSOC CANCER RESEARCH
Place of Publication:	PHILADELPHIA
ISSN:	1538-7445
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language Oncology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/47010